tiprankstipranks
Trending News
More News >
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
Advertisement

Arrowhead Pharmaceuticals (ARWR) Revenue

Compare
1,540 Followers

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had a revenue of 542.71M in the quarter ending Mar 31, 2025, with 21608.36%. This bring the company's revenue in the last twelve months to 545.21M, Decreased 21708.36%. In the fiscal year ending Sep 30, 2024, Arrowhead Pharmaceuticals had annual revenue of 3.55M with -98.52% growth.
Revenue (ttm)
545.21M
Revenue Growth
1436.97%
P/S Ratio
619.53
Revenue/Employee
$5,831
Employees
609
Market Cap
$2.20B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Sep 30, 2024
3.55M-237.18M-98.52%
Sep 30, 2023
240.74M-2.50M-1.03%
Sep 30, 2022
243.23M104.94M+75.89%
Sep 30, 2021
138.29M50.30M+57.16%
Sep 30, 2020
87.99M-80.80M-47.87%
Sep 30, 2019
168.80M152.65M+945.67%
Sep 30, 2018
16.14M-15.27M-48.60%
Sep 30, 2017
31.41M31.25M+19,736.49%
Sep 30, 2016
158.33K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis